Evidence map›Paper›PMID 39507776›Full record

ArticleVeterinary world2024

Characterizing the bacteriophage PKp-V1 as a potential treatment for ESBL-producing hypervirulent K1

Muhammad Usama Tariq, Saima Muzammil, Usman Ali Ashfaq, Muhammad Imran Arshad, Muhammad Shafique, Hasan Ejaz, Mohsin Khurshid, Lienda Bashier Eltayeb, Bi Bi Zainab Mazhari, Mohammed Yagoub Mohammed Elamir and 3 more

Abstract read
In one paragraph

Article in Veterinary world, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Muhammad Usama TariqInstitute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.
Saima MuzammilInstitute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.
Usman Ali AshfaqDepartment of Bioinformatics and Biotechnology, Government College University Faisalabad, Faisalabad, Pakistan.
Muhammad Imran ArshadInstitute of Microbiology, University of Agriculture, Faisalabad, Pakistan.
Muhammad ShafiqueInstitute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.
Hasan EjazDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka 72388, Saudi Arabia.
Mohsin KhurshidInstitute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.
Lienda Bashier EltayebDepartment of Medical Laboratory Sciences, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University-Al-Kharj, 11942 Riyadh, Saudi Arabia.
Bi Bi Zainab MazhariDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Qurayyat 75911, Saudi Arabia.
Mohammed Yagoub Mohammed ElamirDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka 72388, Saudi Arabia.
Helal F Al-HarthiBiology Department, Turabah University College, Taif University 21995, Saudi Arabia.
Muhammad Hidayat RasoolInstitute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.
Bilal AslamInstitute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aim: The dearth of new antibiotics necessitates alternative approaches for managing infections caused by resistant superbugs. This study aimed to evaluate the lytic potential of the purified bacteriophage PKp-V1 against extended-spectrum β-lactamase (ESBL) harboring hypervirulent Materials and Methods: A total of 50 samples were collected from various veterinary specimens to isolate Results: Among 17 (34%) confirmed Conclusion: Although the incidence of ESBL-infected

Indexed as

antibiotic resistancebacteriophageKlebsiella pneumoniaeveterinary

Identifiers

PMID39507776
PMCPMC11536733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.